← back to search

Chang Han

Beijing University of Chemical Technology · CN
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer-related molecular mechanisms research, and MicroRNA in disease regulation.
h-index
25
citations
8,652
works
95
NIH funding
primary concept
Biology
email

Recent publications

Ultra-stable threose nucleic acid-based biosensors for rapid and sensitive nucleic acid detection and in vivo imaging
Acta Biomaterialia 2024cited by 6position: middledoi
The potential mechanisms and material basis of Fuzheng Jiedu decoction broad-spectrum inhibiting coronaviruses
Virologica Sinica 2024cited by 5position: middledoi
Identification of 113 new histone marks by CHiMA, a tailored database search strategy
Science Advances 2023cited by 15position: middledoi
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Cell 2020cited by 527position: middledoi
First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers
Journal of Clinical Oncology 2019cited by 592position: middledoi
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
New England Journal of Medicine 2018cited by 3,127position: middledoi
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Cancer Discovery 2018cited by 1,588position: middledoi
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
Cancer Cell 2018cited by 893position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

William J. Geese · Bristol-Myers Squibb (United States)2 papers (2018–2018)Joseph D. Szustakowski · Bristol-Myers Squibb (Germany)2 papers (2018–2018)Matthew D. Hellmann · Weill Cornell Medicine2 papers (2018–2018)Jong Seok Lee · Seoul National University1 papers (2018–2018)Yali Fu · Shanghai Medical College of Fudan University1 papers (2018–2018)Pamela Salman · Instituto Profesional Providencia1 papers (2018–2018)Xiaoping An · Southern Medical University1 papers (2024–2024)Fred R. Hirsch · Mount Sinai Health System1 papers (2018–2018) · 1 papers (2018–2018)Shiting He · Guangdong University of Technology1 papers (2024–2024)Chiying Zhu · Guangzhou University of Chinese Medicine1 papers (2024–2024)Tudor–Eliade Ciuleanu · Iuliu Hațieganu University of Medicine and Pharmacy1 papers (2018–2018)Helena Linardou · National and Kapodistrian University of Athens1 papers (2018–2018)Clarisse Audigier-Valette · Université de Toulon1 papers (2018–2018)Adam Płużański · National Institute of Oncology1 papers (2018–2018)Shu‐Shan Du · China Pharmaceutical University1 papers (2024–2024)Gregory A. Otterson · Johns Hopkins University1 papers (2018–2018)Hoi Ching Chu · City University of Hong Kong1 papers (2024–2024)Pik Kwan Lo · City University of Hong Kong1 papers (2024–2024)Di Zhang · Shandong University of Technology1 papers (2023–2023)